Revvity signals beyond the news: 25+ signals from 3 sources
The latest Revvity signal on this page is from Nov 17, 2026 (Patents): "REVVITY HEALTH SCIENCES, INC.'s patent output is accelerating: 11 grants in the past year, 2 in the past 30 days." The busiest sources: Glassdoor (15+), Patents (6) and Reddit (4).
PublicBiotechnology Research1,001 to 5,000 employeesrevvity.comLinkedIn
Get Revvity's live signals in Claude or ChatGPT, or by API
What changed at Revvity this week? Use Autobound signals for revvity.com.- Signals
- 25+
- Sources
- 3
- Last 90 days
- 24
- Latest
- Nov 17, 2026
Source: Autobound Signal API · 28 signals tracked for Revvity · updated
Other signals · latest 10
Latest Revvity signals by source
25+ signals for Revvity across 3 sources.
Patents · Patent pace
REVVITY HEALTH SCIENCES, INC.'s patent output is accelerating: 11 grants in the past year, 2 in the past 30 days.
Over the past year REVVITY HEALTH SCIENCES, INC. received 11 US patent grants; the recent pace (3 in 90 days) is accelerating versus its trailing baseline.
- Grants, 12 months
- 11
- Grants, 90 days
- 3
- Grants, 30 days
- 2
- Pace
- Accelerating
Glassdoor · Cross functional collaboration issues
Employees report silos and operational disconnects between departments across multiple reviews
Staff across roles including sales and regulatory affairs highlight difficulties in cross-departmental project engagement and misalignment on priorities due to organizational silos.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 9
- Review window
- Oct 25, 2026 to Nov 10, 2026
Glassdoor · Compensation dissatisfaction
Several employees highlight pay levels that trail market standards for their roles
Current and former staff from customer service and scientific roles express that compensation does not align with the expected workload or broader sector averages.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 9
- Review window
- Oct 25, 2026 to Nov 10, 2026
Patents · Patent grant
Revvity Health Sciences was granted a patent for modular lab liquid handling.
In November 2026 Revvity Health Sciences patented a liquid-handling platform for laboratory workflows, enabling pipettors to use interchangeable tools for sample processing.
- Patent title
- Lab tools and laboratory liquid handling systems and methods including same
- Grant date
- Nov 10, 2026
- Inventors
- Vladimir Krasheninin, Traci Lipman
Glassdoor · Growth opportunities
Employees identify unclear career advancement paths and limited professional growth
A regulatory affairs specialist and other staff note that pathways for promotion and strategic career advancement could be more clearly defined to improve employee engagement.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 9
- Review window
- Oct 25, 2026 to Nov 10, 2026
Patents · Patent grant
Revvity Health Sciences was granted a patent for gamma-detector calibration.
In November 2026 Revvity Health Sciences patented a calibration system for checking gamma-detector performance in nuclear imaging and radiation measurement equipment.
- Patent title
- Gamma source devices and related systems and methods
- Grant date
- Nov 3, 2026
- Inventors
- Michael Belobraydich, Richard Harazin, Richard E. Pelc
Patents · Patent counsel
REVVITY HEALTH SCIENCES, INC. uses Myers Bigel, P.A. as outside IP counsel.
Myers Bigel, P.A. is the attorney of record on REVVITY HEALTH SCIENCES, INC.'s recent US patent work, including a grant in 2026-11.
- Law firm
- Myers Bigel, P.A.
- Law firm domain
- myersbigel.com
- Matter date
- Nov 3, 2026
Reddit · Customer feedback
Revvity faces strong criticism from a ChemDraw user for charging $1,350 per person per year while removing perpetual licensing and delivering minimal product innovation.
Post: "Reverse engineered ChemDraw then made it 5x more usable. Open source. Signed on Mac and Win."
- Subreddit
- r/Chempros
- Upvotes
- 48
- Comments
- 13
- Sentiment
- Negative
Reddit · Customer feedback
Revvity (PerkinElmer) customer expresses frustration over spending a week in unhelpful email correspondence trying to obtain 17-year-old legacy software required to operate an Enspire 2300 plate...
Post: "Dear lab supply companies - please give me the free software to the $20k instrument I already own"
- Subreddit
- r/labrats
- Upvotes
- 839
- Comments
- 53
- Sentiment
- Negative
Reddit · Buying intent
A researcher is evaluating Revvity alongside its Horizon Discovery unit to purchase sgRNA reagents for an arrayed CRISPRa screen of 200-300 genes.
Post: "CRISPRa arrayed screen"
- Subreddit
- r/labrats
- Upvotes
- 1
- Comments
- 2
- Sentiment
- Neutral
Showing 10 of 25+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Revvity with the Signal API
One POST /v1/companies/enrich call with revvity.com returns Revvity signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "revvity.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Other signals at related companies
Questions about Revvity other signals
What signals does Autobound track for Revvity besides news and filings?
What are people saying about Revvity online?
What do employees say about working at Revvity?
Has Revvity been granted patents recently?
Page updated , the date of the newest row on this page.
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .